Immune Checkpoint Blockade Improves Chemotherapy in the PyMT Mammary Carcinoma Mouse Model

Despite the success of immune checkpoint blockade in cancer, the number of patients that benefit from this revolutionary treatment option remains low. Therefore, efforts are being undertaken to sensitize tumors for immune checkpoint blockade, which includes combining immune checkpoint blocking agent...

Descripción completa

Detalles Bibliográficos
Autores principales: Sirait-Fischer, Evelyn, Olesch, Catherine, Fink, Annika F., Berkefeld, Matthias, Huard, Arnaud, Schmid, Tobias, Takeda, Kazuhiko, Brüne, Bernhard, Weigert, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513675/
https://www.ncbi.nlm.nih.gov/pubmed/33014872
http://dx.doi.org/10.3389/fonc.2020.01771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513675/
https://www.ncbi.nlm.nih.gov/pubmed/33014872
http://dx.doi.org/10.3389/fonc.2020.01771

Ejemplares similares